areta has its own portfolio of purified monoclonal antibodies and related hybridoma clones specific for non-conventional antigens including cancer surface antigens, fibrinolytic and angiogenic factors, bacterial endotoxin, cell-cycle regulation factors, Alzheimer's disease related proteins, haematopoietic factors, HIV envelope, core and regulatory proteins.

areta's portfolio

High purity (>95%) murine monoclonal antibodies produced in bioreactors.

mAb anti-EPO: Erythropoietin
mAb anti-Fhit: Fhit (Tumor suppressor gene)
mAb anti-GCSF: GCSF (Granulocite Colony Stimulating Factor)
mAb anti-Ligase: DNA Ligase I
mAb anti-Tcl-1: Tcl-1 (T cell leukemia1 oncogene)
mAb anti-Urokinase: Urokinase (Panel of antibodies against different domains)
mAb anti-VEGF: VEGF (Vascular Endothelial Growth Factor)
mAb anti-WWOX: WWOX (tumor suppressor gene)

Price and additional information upon request.

Monoclonal antibodies: All areta's monoclonal antibodies

Portfolio: Full portfolio